Guangdong Taiantang Pharmaceutical Co Ltd - Class A

SZSE:002433 (China)   Class A
Â¥ 0.51 (0%) Jun 7
At Loss
P/B:
1.03
Market Cap:
Â¥ 391.05M ($ 53.95M)
Enterprise V:
Â¥ 1.55B ($ 213.36M)
Volume:
-
Avg Vol (2M):
1.49M
Volume:
-
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Guangdong Taiantang Pharmaceutical Co Ltd ( SZSE:002433 ) from 2010 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Guangdong Taiantang Pharmaceutical stock (SZSE:002433) PE ratio as of Jun 10 2024 is 0. More Details

Guangdong Taiantang Pharmaceutical Co Ltd (SZSE:002433) PE Ratio (TTM) Chart

To

Guangdong Taiantang Pharmaceutical Co Ltd (SZSE:002433) PE Ratio (TTM) Historical Data

Total 1206
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Guangdong Taiantang Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 At Loss 2024-04-05 At Loss
2024-06-07 At Loss 2024-04-03 At Loss
2024-06-06 At Loss 2024-04-02 At Loss
2024-06-05 At Loss 2024-04-01 At Loss
2024-06-04 At Loss 2024-03-29 At Loss
2024-06-03 At Loss 2024-03-28 At Loss
2024-05-31 At Loss 2024-03-27 At Loss
2024-05-30 At Loss 2024-03-26 At Loss
2024-05-29 At Loss 2024-03-25 At Loss
2024-05-28 At Loss 2024-03-22 At Loss
2024-05-27 At Loss 2024-03-21 At Loss
2024-05-24 At Loss 2024-03-20 At Loss
2024-05-23 At Loss 2024-03-19 At Loss
2024-05-22 At Loss 2024-03-18 At Loss
2024-05-21 At Loss 2024-03-15 At Loss
2024-05-20 At Loss 2024-03-14 At Loss
2024-05-17 At Loss 2024-03-13 At Loss
2024-05-16 At Loss 2024-03-12 At Loss
2024-05-15 At Loss 2024-03-11 At Loss
2024-05-14 At Loss 2024-03-08 At Loss
2024-05-13 At Loss 2024-03-07 At Loss
2024-05-10 At Loss 2024-03-06 At Loss
2024-05-09 At Loss 2024-03-05 At Loss
2024-05-08 At Loss 2024-03-04 At Loss
2024-05-07 At Loss 2024-03-01 At Loss
2024-05-06 At Loss 2024-02-29 At Loss
2024-05-03 At Loss 2024-02-28 At Loss
2024-05-02 At Loss 2024-02-27 At Loss
2024-04-30 At Loss 2024-02-26 At Loss
2024-04-29 At Loss 2024-02-23 At Loss
2024-04-26 At Loss 2024-02-22 At Loss
2024-04-25 At Loss 2024-02-21 At Loss
2024-04-24 At Loss 2024-02-20 At Loss
2024-04-23 At Loss 2024-02-19 At Loss
2024-04-22 At Loss 2024-02-16 At Loss
2024-04-19 At Loss 2024-02-09 At Loss
2024-04-18 At Loss 2024-02-08 At Loss
2024-04-17 At Loss 2024-02-07 At Loss
2024-04-16 At Loss 2024-02-06 At Loss
2024-04-15 At Loss 2024-02-05 At Loss
2024-04-12 At Loss 2024-02-02 At Loss
2024-04-11 At Loss 2024-02-01 At Loss
2024-04-10 At Loss 2024-01-31 At Loss
2024-04-09 At Loss 2024-01-30 At Loss
2024-04-08 At Loss 2024-01-29 At Loss

Guangdong Taiantang Pharmaceutical Co Ltd (SZSE:002433) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Guangdong Taiantang Pharmaceutical Co Ltd is a China-based pharmaceutical company engaged in the research, manufacture and sale of high-effect skin-drugs.